# Harm Reduction With Pharmacotherapy (HaRP)

> **NCT01932801** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 308 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** XR-NTX
- **OTHER:** Placebo
- **BEHAVIORAL:** HRC

## Key facts

- **NCT ID:** NCT01932801
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-01
- **Primary completion:** 2018-10-11
- **Final completion:** 2019-06-30
- **Target enrollment:** 308 (ACTUAL)
- **Last updated:** 2023-05-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932801, "Harm Reduction With Pharmacotherapy (HaRP)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01932801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*